Applied Health Economics & Outcomes Research (AHEOR) is an academic discipline that establishes the efficacy of a product, service, or treatment; compares its effectiveness to other interventions; and considers its incremental cost efficiency to determine optimal clinical application and overall economic value.
The Master's of Science (MS) builds upon the foundation concepts presented in the Graduate Certificate and focuses on the advanced application of concepts necessary for the modern practice of AHEOR in research and industry settings. This option contains ten online courses and a capstone project, which is specifically designed to enhance the student’s career trajectory. This option can be completed in two years.
Learn more about the program here.
Submissions from 2022
Submissions from 2021
Machine Learning Optimization of ICU Care: A Cost-Effectiveness Model, Mario V. Fusaro, MD
Medical Affairs and Successful Medical Device Strategies: Best Practices for Return on Intelligence (ROI), Haytham Gareer, MD, MBA, PhD
Budget Impact Analysis of Semaglutide for Weight-loss Management in Overweight and Obese U.S. Adults, Tobin Sebastian, PharmD
Submissions from 2020
Phyllodes Tumor of the Breast: Association Between Age, Surgical Treatment and Survival, Alberto Batista, PharmD, AHEOR Student and Karen Walsh, MS, MBA
The Prevalence of Microalbuminuria in Adolescents with Obesity in United States Using the National Health and Nutrition Examination Survey (NHANES) Data 2011-2016TA 2011-2016, Fournier Janine, PharmD, AHEOR Student and Karen Walsh, MS, MBA
The Impact of Biologic Therapy on Health-related Quality of Life in Pediatric Psoriasis, Lauren Siegel, MS, AHEOR Student and Alex Niyazov, PharmD, MPH
Systematic literature review on the effect of antidepressants on sleep impairment in major depressive disorder, Jennifer Voelker, MS AHEOR Student and J McAna
Submissions from 2018
A Systematic Literature Review and Economic Evaluation with a Meta-Analysis of Randomized Control Trials Focusing on Symptom Reduction in Adults Ages 18 and Older Treated by Either Esomeprazole, Omeprazole, Lansoprazole, Rabeprazole, or Pantroprazole for Diagnosed Reflux Disease in North America and Europe, Kajan Gnanasakthy
Submissions from 2017
Submissions from 2016
The Economic Value of Biosimilars, Samantha Simpson